Skip to main content

Search
News

Seattle biotech's rare approach takes cancer fight to next level

|

Seattle biotech's rare approach takes cancer fight to next level

May 28, 2014

http://www.king5.com/health/Seattle-Juno-Therapeutics-cancer-fight--260931231.html

 

Source - KING 5 TV


Medical research institutions may all target the same maladies, but they regularly compete with each other over talent and funding. So how unusual is it for three of the country's top cancer research facilities to combine their efforts to form a biotech startup company? "It is relatively rare to bring three institutions of that caliber together to collaborate rather than to compete," said Hans Bishop, CEO and co-founder of Juno Therapeutics. It's now his job to help build a business model for Juno, and commercialize the lab work that Fred Hutchinson Cancer Research Center, Seattle Children's Research Institute and New York's Memorial Sloan Kettering are pursuing in immunotherapy.

Contact Information for Press

If you have not worked with Seattle Children’s before, please read our press policy before contacting us.

The best way to reach the public relations team is via email at press@seattlechildrens.org. This inbox is monitored seven days a week, during and after business hours, on weekends and on holidays.

Phone: 206-987-4500
(8:30 a.m. to 5:30 p.m. Pacific time, Monday–Friday only)

Note: This contact information is for members of the media only. For general hospital or research questions, please call the hospital switchboard at 206-987-2000.

Latest News

Seattle Children’s studying new ways to treat infant brain injuries
8.21.14 — Q13 Fox

A brain injury is serious for anyone, but for infants they can be devastating. Dr. Dennis Mayock of Seattle Children’s, the ... cont.

Training Physicians for Empathy
8.8.14 — HealthLeaders Media

Improving Clinical Management of Stillbirth is an educational session sponsored by the Global Alliance to Prevent Prematurity ... cont.

Remembering Daniel and the Legacy He Left Behind
8.5.14 — On the Pulse Blog

In my last post about “The Fault in Our Stars,” I made a comment about how most patients live, if not thrive after their ... cont.